# A Biotype Enhancing Strategy For The Patient Undergoing Accelerated Orthodontics

> **NCT02866929** · PHASE4 · UNKNOWN · sponsor: **CES University** · enrollment: 40 (actual)

## Conditions studied

- Class I Malocclusion
- Other Periodontal Diseases
- Thin Gingival Biotype

## Interventions

- **PROCEDURE:** Decortication
- **DEVICE:** Orthodontics
- **DRUG:** Mucograft

## Key facts

- **NCT ID:** NCT02866929
- **Lead sponsor:** CES University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2018-06
- **Final completion:** 2018-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2018-07-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02866929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02866929, "A Biotype Enhancing Strategy For The Patient Undergoing Accelerated Orthodontics". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02866929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*